Back to Search
Start Over
Lenalidomide differently modulates CD20 antigen surface expression on chronic lymphocytic leukemia B-cells.
- Source :
-
Leukemia & lymphoma [Leuk Lymphoma] 2015; Vol. 56 (8), pp. 2458-9. Date of Electronic Publication: 2015 Jan 29. - Publication Year :
- 2015
- Subjects :
- Antigens, CD20 genetics
Gene Expression Regulation, Leukemic drug effects
Humans
Lenalidomide
Leukemia, Lymphocytic, Chronic, B-Cell genetics
Thalidomide pharmacology
Antigens, CD20 metabolism
Antineoplastic Agents pharmacology
Cell Membrane metabolism
Leukemia, Lymphocytic, Chronic, B-Cell metabolism
Thalidomide analogs & derivatives
Subjects
Details
- Language :
- English
- ISSN :
- 1029-2403
- Volume :
- 56
- Issue :
- 8
- Database :
- MEDLINE
- Journal :
- Leukemia & lymphoma
- Publication Type :
- Editorial & Opinion
- Accession number :
- 25547653
- Full Text :
- https://doi.org/10.3109/10428194.2014.999329